drugs with tirzepatide Eli Lilly weight loss drug data released Mounjaro and Zepbound Are No
Description
iScience 24 , 116 (2021)
Rushing to higher doses in week one would likely cause severe nausea and dropout rates that contraindicate the entire treatment course
Whats more, many people using the weekly injectable experience slowed or stopped weight loss even if they did lose weight at first
It can interact with several medicines, increasing the risk of side effects, particularly gastrointestinal bleeding
Diets and exercise aren't always enough for everyone
